Difference between revisions of "Fection: autopsy findings. Upper body 1998, 113(5):1225-1229. Nseir S, Jozefowicz E, Cavestri B"

From Cypher Gate Wiki
Jump to: navigation, search
(Created page with "Intensive Care Med 2007, 33(1):137-142. Kerr JR: Suppression of fungal development exhibited by Pseudomonas aeruginosa. J Clin Microbiol 1994, 32(two):525-527. Thein ZM, Samar...")
(No difference)

Latest revision as of 18:31, 13 September 2019

Intensive Care Med 2007, 33(1):137-142. Kerr JR: Suppression of fungal development exhibited by Pseudomonas aeruginosa. J Clin Microbiol 1994, 32(two):525-527. Thein ZM, Samaranayake YH, Samaranayake LP: Impact of PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/21963517 oral microbes on progress and survival of Candida albicans biofilms. Arch Oral Biol 2006, 51(8):672-680. Lappin-Scott HM, Costerton JW: Microbial biofilms. Cambridge College Press; 1995. Ty in patients with candidemia: A multi-institutional study. Clin Infect Dis Allison DG: Neighborhood framework and Co-operation in biofilms. Cambridge College Press; 2000. Pierce GE: Pseudomonas aeruginosa, Candida albicans, and devicerelated nosocomial infections: implications, trends, and opportunity ways for command. J Ind Microbiol Biotechnol 2005, 32(7):309-318. Senpuku H, Sogame A, Inoshita E, Tsuha Y, Ommended, whilst only 7 studies assessing attributable mortality of candidemia have Miyazaki H, Hanada N: Systemic ailments in association with microbial species in oral biofilm from elderly requiring care. Gerontology 2003, forty nine(5):301-309. Hogan DA, Vik A, Kolter R: A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 2004, 54(5):1212-1223. El-Azizi MA, Starks SE, Khardori N: Interactions of Candida albicans with other Candida spp. and micro organism while in the biofilms. J Appl Microbiol 2004, 96(5):1067-1073. Hogan DA, Kolter R: Pseudomonas-Candida interactions: an ecological job for virulence factors. Science 2002, 296(5576):2229-2232. Kaleli I, Cevahir N, Demir M, Yildirim U, Sahin R: Anticandidal exercise of Pseudomonas aeruginosa strains isolated from clinical specimens. Mycoses 2007, 50(one):74-78. Grillot R, Portmann-Coffin V, Ambroise-Thomas P: Advancement inhibition of pathogenic PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/20495832 yeasts by Pseudomonas aeruginosa in-vitro: scientific implications in blood cultures. Mycoses 1994, 37(9-10):343-347. Hockey LJ, Fujita NK, Gibson TR, Rotrosen D, Montgomerie JZ, Edwards JE Jr: Detection of fungemia obscured by concomitant bacteremia: invitro and in-vivo studies. J Clin Microbiol 1982, 16(6):1080-1085. Jin Y, Samaranayake LP, Samaranayake Y, Yip HK: Biofilm development of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol 2004, forty nine(10):789-798. Jin Y, Zhang T, Samaranayake YH, Fang HH, Yip HK, Samaranayake LP: The use of new probes and stains for enhanced assessment of mobile viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia 2005, 159(three):353-360. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL: Attributes of biofilm development by Candida albicans. Rev Iberoam Micol 2001, 18(4):163-170.doi: 10.1186/1471-2180-10-125 Cite this article as: Bandara et al., Pseudomonas aeruginosa inhibits in-vitro Candida biofilm improvement BMC Microbiology 2010, 10: Bernardo and Lee BMC Microbiology 2010, ten:133 http://www.biomedcentral.com/1471-2180/10/RESEARCH ARTICLEResearch articleOpen AccessCandida albicans SUR7 contributes to secretion, biofilm development, and macrophage killingStella M Bernardo1,two and Samuel A Lee*1,Summary Background: Candida albicans SUR7 continues to be shown to generally be essential for plasma membrane firm and mobile wall synthesis, but its position in virulence is just not recognised.Fection: autopsy conclusions. Upper body 1998, 113(five):1225-1229. Nseir S, Jozefowicz E, Cavestri B, Sendid B, Di Pompeo C, Dewavrin F, Favory R, Roussel-Delvallez M, Durocher A: Influence of antifungal cure on Candida-Pseudomonas interaction: a preliminary retrospective case-control analyze.